+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes



Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes



Value in Health 15(2): 249-254



To evaluate the cost-effectiveness of a socioculturally adapted collaborative depression care program among low-income Hispanics with diabetes. A randomized controlled trial of 387 patients with diabetes (96.5% Hispanic) with clinically significant depression followed over 18 months evaluated the cost-effectiveness of the Multifaceted Diabetes and Depression Program aimed at increasing patient exposure to evidence-based depression psychotherapy and/or pharmacotherapy in two public safety net clinics. Patient medical care costs and utilization were captured from Los Angeles County Department of Health Services claims records. Patient-reported outcomes included Short-Form Health Survey-12 and Patient Health Questionnaire-9-calculated depression-free days. Intervention patients had significantly greater Short-Form Health Survey-12 utility improvement from baseline compared with controls over the 18-month evaluation period (4.8%; P < 0.001) and a corresponding significant improvement in depression-free days (43.0; P < 0.001). Medical cost differences were not statistically significant in ordinary least squares and log-transformed cost regressions. The average costs of the Multifaceted Diabetes and Depression Program study intervention were $515 per patient. The program's cost-effectiveness averaged $4053 per quality-adjusted life-year per MDDP recipient and was more than 90% likely to fall below $12,000 per quality-adjusted life-year. Socioculturally adapted collaborative depression care improved utility and quality of life in predominantly low-income Hispanic patients with diabetes and was highly cost-effective.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052369460

Download citation: RISBibTeXText

PMID: 22433755

DOI: 10.1016/j.jval.2011.09.008


Related references

Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care 33(4): 706-713, 2010

Depression and diabetes among low-income Hispanics: design elements of a socioculturally adapted collaborative care model randomized controlled trial. International Journal of Psychiatry in Medicine 39(2): 113-132, 2009

Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women. Archives of General Psychiatry 62(8): 868-875, 2005

Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care. American Journal of Preventive Medicine 51(1): E13-E20, 2016

Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer. Journal of Psychosomatic Research 79(6): 465-470, 2015

Cost-effectiveness analysis of a collaborative care programme for depression in primary care. Journal of Affective Disorders 159: 85-93, 2014

One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer. Psychiatric Services 62(2): 162-170, 2011

Technology-facilitated depression care management among predominantly Latino diabetes patients within a public safety net care system: comparative effectiveness trial design. Contemporary Clinical Trials 37(2): 342-354, 2014

Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Archives of General Psychiatry 67(8): 812-821, 2010

Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial. Bmj Open 6(10): E012514, 2016

Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technology Assessment 20(14): 1-192, 2016

Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial. Bmc Psychiatry 13: 128, 2013

Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosomatic Medicine 60(2): 143-149, 1998

Cost-effectiveness of a disease management program for major depression in elderly primary care patients. Journal of General Internal Medicine 21(10): 1020-1026, 2006

Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis. Lancet. Diabetes and Endocrinology 4(11): 922-932, 2016